scholarly article | Q13442814 |
P50 | author | Martin Hauer-Jensen | Q87074114 |
P2093 | author name string | Junru Wang | |
Qiang Fu | |||
Wenze Wang | |||
Marjan Boerma | |||
Herbert A Schmid | |||
Maaike Berbée | |||
P2860 | cites work | The synthetic somatostatin analogue, octreotide, ameliorates acute and delayed intestinal radiation injury | Q73307162 |
The nature of intestinal radiation death | Q73985374 | ||
Effects of growth hormone and insulin-like growth factor-I on radiation enteritis. a comparative study | Q77218612 | ||
Human Mig chemokine: biochemical and functional characterization | Q24678720 | ||
Interleukin 1 is a radioprotector | Q28299497 | ||
Intestinal stem cells and mucosal gut development | Q30435892 | ||
Effects of somatostatin analog SOM230 on cell proliferation, apoptosis, and catecholamine levels in cultured pheochromocytoma cells | Q33337708 | ||
Cytokines and inflammatory bowel disease: a review | Q33731540 | ||
The role of the gastrointestinal tract in postinjury multiple organ failure | Q33835696 | ||
Determination of sample sizes for demonstrating efficacy of radiation countermeasures | Q34565829 | ||
The hematologist and radiation casualties. | Q35591475 | ||
A new hypothesis for microvascular inflammation in shock and multiorgan failure: self-digestion by pancreatic enzymes | Q36086355 | ||
Human mast cells, bacteria, and intestinal immunity | Q36819955 | ||
The gastrointestinal tract stem cell niche | Q36877550 | ||
Radiation damage to the gastrointestinal tract: mechanisms, diagnosis, and management | Q37228299 | ||
Intracellular autoactivation of human cationic trypsinogen mutants causes reduced trypsinogen secretion and acinar cell death | Q37446172 | ||
The antiproliferative effect of somatostatin analogs: clinical relevance in patients with neuroendocrine gastro-entero-pancreatic tumours. | Q37464055 | ||
History and development of radiation-protective agents | Q37532178 | ||
Role of Pancreatic Proteases in the Pathogenesis of Ischemic Enteropathy | Q39148083 | ||
IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. | Q41175127 | ||
Effect of octreotide acetate on pancreatic exocrine function | Q41256214 | ||
The somatostatin analog SOM230 (pasireotide) ameliorates injury of the intestinal mucosa and increases survival after total-body irradiation by inhibiting exocrine pancreatic secretion | Q42553872 | ||
SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile | Q43973971 | ||
The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: a randomized controlled study | Q44105608 | ||
Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model. | Q45872659 | ||
Novel role of the CXC chemokine receptor 3 in inflammatory response to arterial injury: involvement of mTORC1. | Q46212010 | ||
Pharmacokinetic-pharmacodynamic comparison of a novel multiligand somatostatin analog, SOM230, with octreotide in patients with acromegaly | Q46589238 | ||
Induction of cytokines by radioprotective tocopherol analogs | Q46903824 | ||
Growth hormone reduces mortality and bacterial translocation in irradiated rats. | Q47943330 | ||
The substance P and somatostatin interferon-gamma immunoregulatory circuit | Q47966509 | ||
Calcitonin gene-related peptide and substance P regulate the intestinal radiation response. | Q54593964 | ||
Local administration of interleukin-11 ameliorates intestinal radiation injury in rats | Q57216391 | ||
Effect of Somatostatin on Normal and Gastric-Stimulated Cell Proliferation in the Gastric and Intestinal Mucosae of the Rat | Q66924500 | ||
Effect of somatostatin on pancreatic enzyme secretion | Q69052839 | ||
Influence of pancreatic secretion on late radiation enteropathy in the rat | Q70131456 | ||
Prolongation of survival in lethally irradiated dogs by pancreatic duct ligation | Q71592276 | ||
Injurious Effect of Pancreatic Secretions on Postradiation Enteropathy | Q72327296 | ||
Intestinal permeability in humans is increased after radiation therapy | Q73218703 | ||
P433 | issue | 6 | |
P304 | page(s) | 728-735 | |
P577 | publication date | 2011-04-29 | |
P1433 | published in | Radiation Research | Q2446628 |
P1476 | title | Preclinical evaluation of Som230 as a radiation mitigator in a mouse model: postexposure time window and mechanisms of action | |
P478 | volume | 175 |
Q27021962 | Acute radiation syndrome caused by accidental radiation exposure - therapeutic principles |
Q37450663 | Gamma-tocopherol-N,N-dimethylglycine ester as a potent post-irradiation mitigator against whole body X-irradiation-induced bone marrow death in mice |
Q35566671 | Medical Countermeasures for Radiation Exposure and Related Injuries: Characterization of Medicines, FDA-Approval Status and Inclusion into the Strategic National Stockpile. |
Q26823881 | Novel drugs to ameliorate gastrointestinal normal tissue radiation toxicity in clinical practice: what is emerging from the laboratory? |
Q35626587 | Radiation countermeasure agents: an update (2011-2014) |
Q28237189 | Radiation enteropathy--pathogenesis, treatment and prevention |
Q37006942 | Sodium orthovanadate (vanadate), a potent mitigator of radiation-induced damage to the hematopoietic system in mice |
Q64925139 | The effect of pasireotide on intestinal anastomotic healing with and without whole-body irradiation in a rat model. |
Q48072002 | Total Body Irradiation in the "Hematopoietic" Dose Range Induces Substantial Intestinal Injury in Non-Human Primates. |
Search more.